Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000658820 | SCV000619782 | likely benign | not provided | 2021-03-29 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously reported as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 29482223) |
Ce |
RCV000658820 | SCV000780616 | uncertain significance | not provided | 2021-06-01 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000658820 | SCV000854863 | uncertain significance | not provided | 2017-08-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001069420 | SCV001234584 | likely benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2023-10-06 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001333785 | SCV001526465 | uncertain significance | Spinocerebellar ataxia type 6 | 2018-10-25 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. This variant has been previously reported in one patient with sensory ataxia [PMID 29482223] and also present in the general population at a low allele frequency (gnomAD database) |
Revvity Omics, |
RCV000658820 | SCV003830263 | uncertain significance | not provided | 2021-01-20 | criteria provided, single submitter | clinical testing |